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VISUAL ABSTRACT
Carbone, S. et al. J Am Coll Cardiol Basic Trans Science. 2017;2(5):513–25.
HIGHLIGHTS
 The effects of UFA on CRF in patients with
HFpEF are unknown.
 In obese HFpEF patients, UFA
consumption analyzed with a validated
24-h dietary recall was positively associ-
ated with improved body composition,
cardiac diastolic function and greater CRF,
measured as peak VO2 at maximal
cardiopulmonary exercise testing.
Conversely, sugars consumption was
associated with worse CRF.
 In mice, an isocaloric high-fat diet, high in
UFA and low in saturated fat prevented
cardiac diastolic dysfunction measured
with echocardiography and body weight
gain in a model of cardiac dysfunction and
obesity induced by Western diet, despite
similar total caloric intake.
 A high-UFA diet is associated with
preservation of CRF in patients with
HFpEF and cardiac function in the mouse.
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SUMMARY
Heart failure with preserved ejection fraction (HFpEF) is associated with obesity and, indirectly, with
unhealthy diet. The role of dietary components in HFpEF is, however, largely unknown. In this study, the
authors showed that in obese HFpEF patients, consumption of unsaturated fatty acids (UFA), was associated
with better cardiorespiratory ﬁtness, and UFA consumption correlated with better diastolic function and
with greater fat-free mass. Similarly, mice fed with a high-fat diet rich in UFA and low in sugars had
preserved myocardial function and reduced weight gain. Randomized clinical trials increasing dietary
UFA consumption and reducing sugar consumption are warranted to conﬁrm and expand our ﬁndings.
(J Am Coll Cardiol Basic Trans Science 2017;2:513–25) © 2017 The Authors. Published by Elsevier on behalf of
the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
H eart failure (HF) affects more than 38million people worldwide, almost 6 millionin the United States alone, with an
extremely high mortality and hospital admission
rates (1). In one-half of patients diagnosed with HF,
the ejection fraction is preserved (2), and in a large
proportion of those patients, shortness of breath,
exercise intolerance, and reduced cardiorespiratory
ﬁtness (CRF) cannot be attributed to coronary,
valvular, or pericardial disease but rather to an
impairment in diastolic function and/or functional
and structural abnormalities of body composition
compartments, deﬁning the syndrome of heart failure
with preserved ejection fraction (HFpEF) (3).
Peak oxygen consumption (VO2) assessed by car-
diopulmonary exercise testing (CPX) (4) is a measure
of exercise capacity in patients with HF and an
independent predictor of mortality in both HF with
reduced ejection fraction and HFpEF.
HFpEF is a multifactorial disease in which
comorbidities such as obesity and diabetes are
highly prevalent and likely involved in its patho-
physiology (3,5–8).
Obesity contributes to exercise intolerance, inde-
pendent of abnormalities in cardiac function (9).
Obesity results from a sustained positive caloric
balance, therefore caloric restriction is recommended
(10). Caloric restriction leading to 7 kg of weight
loss was associated with a þ1.3 ml $ kg1 $ min1
improvement in peak VO2 in patients with HFpEF,
without changes in cardiac function (11). Preclinical
studies, however, suggest a direct effect of dietary
components, namely, saturated fat and sugars, on
diastolic function, which appears to be at least in part
independent of weight gain (12,13). These changes are
also partially reversible with a low–saturated fat and
low-sugar diet, thus offering a promise for
intervention (12). Conversely, unsaturated
fatty acids (UFAs) exert beneﬁcial effects,
potentially by reducing the synthesis of pro-
inﬂammatory cytokines (14–19). The effects
of a UFA-enriched diet on cardiac diastolic
function and on body composition are largely
unknown, especially in patients with HFpEF.
In clinical studies, the consumption and/or
supplementation of foods rich in UFAs such as
monounsaturated fatty acids (MUFAs) and poly-
unsaturated fatty acids (PUFAs), found in high
proportions in olive oil and nuts, but also in canola
oil and avocado in non-Mediterranean countries,
have been associated with lower major cardiovascu-
lar (CV) event and overall mortality rates in subjects
at high CV risk, independent of the overall dietary
caloric intake or body weight (20,21). Speciﬁc dietary
supplement has also been associated with reduced
mortality in HF, suggesting a major impact of
nutrition in HF (22).
The objective of this study was to determine
whether nutrient consumption, particularly UFAs,
was associated with better cardiac function, body
composition, and CRF in patients with HFpEF and to
test whether an isocaloric diet enriched in UFAs could
prevent cardiac diastolic dysfunction in a mouse
model of diet-induced cardiac dysfunction.
METHODS
CLINICAL STUDY. Subjects . Subjects with symp-
tomatic HFpEF and impaired CRF assessed by
maximal CPX were enrolled. Diagnosis of HFpEF
was based on clinical, laboratory, recent imaging
study, and/or invasive hemodynamic data, according
to the European Society of Cardiology consensus
statement (23).
Major exclusion criteria included moderate to
severe valvular heart disease, pericardial disease,
SEE PAGE 526
AB BR E V I A T I O N S
AND ACRONYM S
CPX = cardiopulmonary
exercise testing
CRF = cardiorespiratory ﬁtness
CV = cardiovascular
DT = deceleration time
FFM = fat-free mass
FM = fat mass
HF = heart failure
HFpEF = heart failure with
preserved ejection fraction
IQR = interquartile range
MUFA = monounsaturated
fatty acid
PUFA = polyunsaturated fatty
acid
SFA = saturated fatty acid
UFA = unsaturated fatty acid
VO2 = oxygen consumption
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restrictive cardiomyopathy, pulmonary artery hyper-
tension (group I), persistent or permanent atrial
ﬁbrillation, active cancer or prior diagnosis within the
past 10 years (excluding carcinoma in situ), chronic
autoimmune or autoinﬂammatory disease, stage IV
or V renal impairment, severe obstructive pulmonary
disease, anemia, mechanical limitation to exertion
due to musculoskeletal or neurological disease, and
other conditions that may affect the completion or
interpretation of maximal (i.e., respiratory exchange
ratio >1.0) CPX, such as myocardial ischemia, un-
controlled hypertension, and chronotropic incompe-
tence (24). The local Institutional Review Board
approved the study, and all patients provided written
informed consent.
Dietary assessment . Subjects underwent standard-
ized 24-h dietary recall. They were asked by the
nutritionist to recall foods and beverages consumed in
the prior 24 h in a structured fashion. Dietary intake
data gathered by interview was governed by a stan-
dardized 5-pass interview approach in which items are
listed, reviewed, then described in detail (including
preparation), quantiﬁed, probed for frequently
forgotten foods, and eventually reviewed again
(25,26). Data were analyzed using the Nutrition Data
System for Research, a computer-based software
application developed at the University of Minnesota
Nutrition Coordinating Center. The Nutrition Coordi-
nating Center’s Food and Nutrient Database served as
the source of food composition information in the
Nutrition Data System for Research. Values for calories
and nutrients consumption (i.e., MUFAs, PUFAs, total
fat, total carbohydrates) expressed in total grams per
day and percentage of total calories were calculated
from the structured dietary recall interview.
CPX. Subjects underwent symptom-limited CPX,
following the American College of Cardiology and
American Heart Association guidelines for exercise
testing (27). CPX was performed using a metabolic
cart interfaced with a treadmill and a conservative
incremental ramping protocol whereby speed and
grade were increased by about 0.6 estimated METs
every 60 s, as previously described (28).
The following parameters were measured and
calculated: peak VO2, minute ventilation, carbon di-
oxide production, and total exercise time according
to standard procedures (27). Peak VO2 was determined
as the highest 10-s interval average obtained from
breath-by-breath measurements of VO2 during the last
30 s of exercise. The peak respiratory exchange ratio
(carbon dioxide production/VO2) was used to deter-
mine maximal effort. A respiratory exchange ratio
>1.0 was the minimally acceptable threshold for
enrollment (4). Of note, the exercise physiologist
performing CPX was blinded to echocardiographic
and body composition parameters.
Body compos i t ion . We measured body composition
using a single-frequency bioelectric impedance anal-
ysis (Quantum IV, RJL System, Clinton Township,
Michigan) to measure fat mass (FM) and fat-free mass
(FFM), calculated FM index and FFM index by
dividing the amount of FM or FFM by the square of
the height expressed in meters, and FFM/FM index by
dividing FFM by FM.
Echocard iography . We used transthoracic Doppler
echocardiography, as recommended by the American
Society of Echocardiography and the European
Association of Cardiovascular Imaging (29,30), to
measure left ventricular end-diastolic and end-
systolic volumes, ejection fraction, and early
transmitral velocity (E) on pulsed-wave Doppler
spectra and early mitral annular velocities by tissue
Doppler averaged between lateral and septal (E0), and
we calculated the E/E0 ratio and the E0 velocity
indexed by deceleration time (DT) (E0DT).
ANIMAL STUDY. Eight-week-old CD-1 male mice
(n ¼ 5 to 8) were fed for 8 weeks with 1 of the following
diets: 1) standard diet; 2) a diet rich in saturated fat
(25.9%) and sugars (30%) and low in UFAs (14.7%)
(Western diet; TD.88137, Envigo, Huntingdon, United
Kingdom); 3) a diet rich in saturated fat (25.9%) and
low in sugars (0%) (high–saturated fatty acid [SFA]
diet; TD.150507, Envigo); or 4) a diet low in saturated
fat (6.5%) and sugars (0%) and high in UFAs (36.7%)
(high-fat UFA diet; TD.160017, Envigo) (Table 1). An
additional group received a high-sugar (30%), low–
saturated fat (6.5%) diet (high-sugar diet; TD.160017,
Envigo) (Supplemental Table 1).
We measured food intake daily, body weight
weekly, and cardiac function every 4 weeks using
transthoracic Doppler echocardiography (Vevo770
Imaging System, VisualSonic, Toronto, Ontario,
Canada) and a 30-MHz probe, to measure cardiac
systolic and diastolic function, as previously
described (31). Experiments were performed
following National Institutes of Health guidelines
and approved by the Institutional Animal Care and
Use Committee.
STATISTICAL ANALYSIS. For the clinical study, data
are reported as median (interquartile ranges [IQRs])
for potential deviation from the Gaussian distribu-
tion. Discrete variables are reported as numbers and
percentages. We assessed for correlations between
CRF parameters and dietary variables using the
Spearman rank test. Correlations between dietary
variables and body composition parameters were also
performed. A correlation was considered signiﬁcant
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at p < 0.05. To further assess the separate contribu-
tion of UFAs and SFAs, we performed a multivariate
analysis using a linear regression method after
determination of nonsigniﬁcant deviation from the
Gaussian distribution of the 2 variables using the
Kolmogorov-Smirnov test (p ¼ 0.20 and p ¼ 0.12,
respectively).
For the animal study, because of the low expected
variance within the groups, values are expressed as
mean and SEM. The differences between groups were
assessed using analysis of variance followed by
the Student t test for unpaired data to compare the
individual groups. SPSS version 23.0 (IBM, Armonk,
New York) was used for statistical analyses.
RESULTS
CLINICAL CHARACTERISTICS. Major demographics
and characteristics are summarized in Table 2.
Fourteen patients (61%) were female, 13 (57%)
African American and the remaining Caucasian, and
the median age was 53 years (IQR: 48 to 57 years).
The majority of patients had hypertension (n ¼ 21
[91%]) and type 2 diabetes (n ¼ 16 [70%]). All sub-
jects were obese (body mass index $30 kg/m2), with
16 subjects (70%) being morbidly obese (body mass
index $40 kg/m2).
DIETARY ASSESSMENT. Median daily total calories
consumption was 2,066 kcal (IQR: 1,897 to 2,642 kcal),
and percentages of calories from total fat, total car-
bohydrates, and total proteins were 38.3% (IQR:
29.7% to 45.6%), 47.7% (IQR: 38.4% to 56.8%), and
14.1% (IQR: 12.7% to 16.1%), respectively (Table 2).
When the type of fat was taken into consideration,
median grams and percentage of calories from SFA
were 25.6 g (IQR: 23.5 to 35.3 g) and 12.7% (IQR: 9.4%
to 15.5%), respectively. Consumption of MUFAs and
PUFAs was 29.4 g (IQR: 24.3 to 34.7 g) and 19.0 g
(IQR: 15.6 to 26.8 g), respectively, while percentage of
calories from MUFAs was 13.8% (IQR: 10.9% to 15.3%)
and 8.6% (IQR: 7.4% to 11.9%) from PUFA. Median
total sugars was 97.3 g (IQR: 75.4 to 153.8 g), repre-
senting 20.3% (IQR: 14.4% to 29.8%) of total calories.
TABLE 2 Baseline Characteristics
Age, yrs 53 (48–57)
Male/female 9 (39.1%)/14 (60.9%)
Race, Caucasian/African American 10 (43.5%)/13 (56.5%)
Major comorbidities
Diabetes mellitus 16 (69.6%)
Coronary artery diseases 8 (34.8%)
Hypertension 21 (91.3%)
Dyslipidemia 14 (60.9%)
Obesity grading
Grade I obesity, BMI $30 and <35 kg/m2 1 (4.4%)
Grade II obesity, BMI $35 and <40 kg/m2 6 (26.1%)
Grade III or severe obesity, BMI $40 kg/m2 16 (69.6%)
Major dietary characteristics
Total daily energy, kcal 2,066 (1,897–2,642)
Fat, % of total energy 38.3 (29.7–45.6)
Monounsaturated fatty acids, % of total energy 13.8 (10.9–15.3)
Polyunsaturated fatty acids, % of total energy 8.6 (7.4–11.9)
Saturated fatty acids, % of total energy 12.7 (9.4–15.5)
Carbohydrates, % of total energy 47.7 (38.4–56.8)
Sugars, % of total energy 20.3 (14.4–29.8)
Protein, % of total energy 14.1 (12.7–16.1)
Sodium, mg 3,252 (2,578–3946)
Cholesterol, mg 248.1 (200.9–476.3)
Body mass and composition
BMI, kg/m2 42.4 (35.2–44.4)
Fat mass, kg 54.8 (49.7–59.6)
Fat mass index, kg/m2 18.8 (16.8–21.3)
Fat-free mass, kg 70.4 (61.0–83.4)
Fat-free mass index, kg/m2 24.0 (21.6–27.7)
Functional capacity
Exercise time, min 8.5 (7.5–9.8)
Respiratory exchange ratio 1.13 (1.04–1.17)
Peak oxygen consumption, ml $ kg1 $ min1 14.4 (11.8–18.5)
Oxygen uptake efﬁciency (slope) 2.2 (1.9–2.5)
Peak oxygen pulse, ml $ min1 14.8 (13.2–17.1)
Doppler echocardiographic parameters
Left ventricular ejection fraction, % 60.4 (57.1–63.0)
Stroke volume, ml 67.2 (57.9–75.6)
E0 velocity, cm/s 8.0 (6.2–8.4)
E/E0 ratio 12.1 (10.1–15.3)
E/A ratio 1.1 (1.0–1.3)
DT, ms 241.0 (195.8–278.1)
E0/DT ratio 0.33 (0.26–0.41)
Biomarkers
NT-proBNP, pg/ml 90 (47–242)
Estimated glomerular ﬁltration rate, ml/min/1.73 m2 68 (52–85)
Values are median (interquartile range) or n (%).
BMI ¼ body mass index; DT ¼ deceleration time; NT-proBNP ¼ N-terminal pro–brain natriuretic
peptide.
TABLE 1 Nutritional Characteristics of Experimental Diets
in the Mouse
Standard
Diet
Western
Diet
High-SFA
Diet
High-UFA
Diet
Proteins 25.0 15.2 15.6 15.6
Total fat 17.0 42.0 43.2 43.2
SFAs (% of total
fatty acids)
14 65 65 15
UFAs (% of total
fatty acids)
86 35 35 85
Total carbohydrates 58 42.7 41.2 41.2
Sugars 0 30 0 0
Cholesterol (% of
weight)
0 0.2 0.2 0.2
Energy density (kcal/g) 3.1 4.5 4.4 4.4
Values are % of total calories.
SFA ¼ saturated fatty acid; UFA ¼ unsaturated fatty acid.
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Median daily sodium consumption was 3,252 mg
(IQR: 2,578 to 3,946 mg), and cholesterol intake was
248.1 mg (IQR: 200.9 to 476.3 mg).
BODY COMPOSITION. The median FM index was
18.8 kg/m2 (IQR: 16.8 to 21.3 kg/m2), and the median
FFM index was 24.0 kg/m2 (IQR: 21.6 to 27.7 kg/m2)
(Table 2).
CPX. Median peak VO2 was 14.4 ml $ kg1 $ min1
(IQR: 11.8 to 18.5ml $ kg1 $ min1), or 52% (IQR: 45%
to 61%) of predicted according to age, sex, and ideal
body weight. Exercise time was 8.5 min (IQR: 7.5 to
9.8 min). The median respiratory exchange ratio was
1.13 (IQR: 1.04 to 1.17) (Table 2).
ECHOCARDIOGRAPHY. The median left ventricular
ejection fraction was 60% (IQR: 57% to 63%), the
median E/E0 ratio was 12.1 (IQR: 10.1 to 15.3), median
E0 was 8.0 cm/s (IQR: 6.2 to 8.4 cm/s), median DT was
241 ms (IQR: 196 to 278 ms), and median E0/DT ratio
was 0.33 (IQR: 0.26 to 0.41) (Table 2).
CORRELATIONS BETWEEN NUTRIENT CONSUMPTION
AND CRF. Correlations are shown in Figure 1. Total fat
in grams or percentage of calories was associated with
FIGURE 1 Fatty Acid Consumption and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction
Total fat consumption was associated with improved peak oxygen consumption (VO2) (A, B). Monounsaturated fat (MUFA) and
polyunsaturated fat (PUFA) consumption in grams (C, E) and in percentage of total calories (D, F) was associated with greater peak VO2.
Unsaturated fat (UFA) consumption (cumulative MUFA and PUFA) (G, H) and saturated fat (SFA) consumption presented a signiﬁcant positive
correlation with peak VO2 (I, J).
Continued on the next page
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greater peak VO2 (R ¼ þ0.63 [p ¼ 0.001] and R ¼ þ0.64
[p ¼ 0.001], respectively). MUFAs measured in grams
or percentage of calories correlated with peak VO2
(R ¼ þ0.56 [p ¼ 0.005] and R ¼ þ0.53 [p ¼ 0.010],
respectively). Similarly, PUFAs in grams or percent-
age of calories correlated with peak VO2 (R ¼ þ0.39
[p ¼ 0.07], R ¼ þ0.53 [p ¼ 0.009], respectively).
When MUFA and PUFA consumption in grams or
as percentage of total calories were combined,
the correlations with peak VO2 became stronger
(R ¼ þ0.45 [p ¼ 0.03] and R ¼ þ0.62 [p ¼ 0.001],
respectively) (Figure 1). SFAs in grams and percentage
of total calories also correlated signiﬁcantly, although
less strongly with peak VO2 (R ¼ þ0.46 [p ¼ 0.03],
R ¼ þ0.49 [p ¼ 0.02], respectively) (Figure 1); in fact, a
multivariate analysis correcting for both SFAs and
UFAs showed that UFAs remained signiﬁcantly
related with peak VO2 (p ¼ 0.017), whereas SFAs no
longer did (p ¼ 0.22).
Total carbohydrates in grams and percentage
of total calories were inversely correlated with peak
VO2 (R ¼ 0.54 [p ¼ 0.008] and R ¼ 0.59 [p ¼ 0.003],
respectively). When sugars (monosaccharides and
disaccharides) were subtracted from total carbohy-
drate consumption, nonsugar carbohydrates showed
a weaker correlation with peak VO2 (R ¼ 0.41,
p ¼ 0.053). In contrast, total grams or percentage of
calories derived from sugars showed an inverse
correlation with peak VO2 (R < 0.43, p < 0.05 for all)
(Supplemental Figure 1), reﬂecting worse CRF
with higher sugar consumption. None of the other
analyzed nutrients (i.e., sodium consumption)
showed a statistically signiﬁcant correlation with
CPX-derived parameters (all values 0.35 < R <þ0.35,
p > 0.05).
CORRELATIONS BETWEEN NUTRIENT CONSUMPTION
AND DIASTOLIC FUNCTION. Signiﬁcant correlations
were found (Figure 2). UFA consumption was associ-
ated with measures of more effective diastolic
function such as higher E0 (R ¼ þ0.38, p ¼ 0.07), lower
DT (R ¼ 0.41, p ¼ 0.04), and higher E0/DT ratio
(R ¼ þ0.48, p ¼ 0.02). SFAs were associated with
E0 (R ¼ þ0.36, p ¼ 0.09) and E0/DT ratio (R ¼ þ0.54,
p ¼ 0.006) but not with DT (R ¼ 0.33, p ¼ 0.12).
CORRELATIONS BETWEEN NUTRIENT CONSUMPTION
AND BODY COMPOSITION. UFA consumption was
associated with a higher percentage of FFM
(R ¼ þ0.49, p ¼ 0.02) and with a more favorable FFM/
FM ratio (R ¼ þ0.43, p ¼ 0.04) (Figure 3). SFA con-
sumption did not correlate with body composition
parameters (R < þ0.1, p > 0.05) (Figure 3).
EXPERIMENTAL STUDY IN MICE. Cumulative 8-week
caloric intake was signiﬁcantly higher in all 3
FIGURE 1 Continued
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 2 , N O . 5 , 2 0 1 7 Carbone et al.
O C T O B E R 2 0 1 7 : 5 1 3 – 2 5 Fat and Sugar Consumption in HFpEF
519
high-fat diets compared with the standard diet
(Figure 4). Mice fed a high–saturated fat and high-
sugar diet (Western diet) or a high–saturated fat
and low-sugar diet (high-SFA diet) presented
signiﬁcantly higher body weight at 8 weeks
compared with those fed standard and high-UFA
diets (Figure 4). Both diets rich in saturated fats
(with and without high sugar content) induced an
impairment in diastolic function, measured as an
increase in isovolumetric relaxation time and
myocardial performance index at 8 weeks, whereas
mice fed the high-UFA diet had preserved diastolic
function (Figure 4).
We evaluated also a group of mice fed a high-sugar,
low–saturated fat diet (high-sugar diet) and found
signiﬁcant worsening of diastolic function compared
with those fed the standard diet (Supplemental
Figure 2). Of note, the degree of impairment in dia-
stolic dysfunction was numerically less than what
was seen with the Western diet (p < 0.05 for both) but
reﬂected lower food intake, and the effects on weight
and cardiac function corrected for food intake were
not statistically different from the Western diet
(Supplemental Figure 2), suggesting a similar toxic
effect, but possibly mice found the high-sugar,
low–saturated fat food less appealing.
FIGURE 2 Fatty Acid Consumption and Myocardial Relaxation in Patients With Heart Failure With Preserved Ejection Fraction
Unsaturated fat (UFA) consumption (cumulative monounsaturated fat [MUFA] and polyunsaturated fat [PUFA]) were associated with
higher E0 (A), lower deceleration time (DT) (C), and higher E0/DT ratio (E). Saturated fatty acids (SFAs) were associated with higher
E0 (B) and higher E0/DT (F), but not with DT (D).
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DISCUSSION
Our data provide a link between dietary UFAs
with CRF in obese patients with HFpEF, indepen-
dent of calorie consumption, potentially through a
protective role of MUFAs and PUFAs on FFM and on
cardiac diastolic function (Figure 5). Total carbohy-
drates, in contrast, were associated with worse
exercise capacity, which was driven by consumption
of sugars.
We also performed an experimental study in
which mice were fed different forms of high-calorie
and high-fat diets, 1 rich in both saturated fat and
sugars (Western diet), 1 rich in saturated fat but low
in sugars, 1 rich in sugars but low in saturated fats,
and another rich in UFAs but low in saturated fat
and sugars; despite no differences in caloric intake,
the increased consumption of saturated fat and of
sugars appears to have an additive deleterious effect
on cardiac diastolic function, whereas a diet
enriched in UFA and low in saturated fat and sugars
did not result in weight gain or in cardiac
dysfunction.
MEDITERRANEAN DIET AND CV OUTCOMES. A diet
rich in UFAs and low in reﬁned carbohydrates and
sugars, typically seen in Mediterranean dietary
patterns, has been associated with favorable CV
outcomes (32,33), lower incidence of HF (34), and
reduced overall mortality (21).
In the PREDIMED (Primary Prevention of Cardio-
vascular Disease With a Mediterranean Diet) study
(20), an unrestricted-calorie supplementation for
almost 5 years with extra-virgin olive oil or nuts,
foods rich in UFAs, in a population at high CV risk
reduced the incidence of major adverse CV events,
the level of N-terminal pro–brain natriuretic peptide
(35), body weight, and waist circumference (36).
EFFECTS OF UFA ON CARDIAC FUNCTION AND
BODY COMPOSITION. Guideline recommendations
on speciﬁc dietary patterns in HFpEF are lacking (37).
A weight-loss intervention through caloric restriction
improved CRF in obese patients with HFpEF (11).
Here we identiﬁed putative mechanisms through
which diet can adversely affect CRF. On the basis of
the knowledge that obesity, particularly the amount
and quality of FM and FFM (9,11,38), and diastolic
FIGURE 3 Fatty Acid Consumption and Body Composition in Patients With Heart Failure With Preserved Ejection Fraction
Unsaturated fatty acid (UFA) consumption is associated with higher fat-free mass (FFM) (A) and with higher FFM/fat mass (FM) index (C).
Saturated fatty acids (SFA) did not correlate with body composition compartments (B, D).
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function contribute to exercise intolerance, and that
UFA consumption is associated with better body
composition and better cardiac diastolic function, an
intervention aimed at increasing UFA and reducing
sugar consumption may be beneﬁcial in patients with
HFpEF (Figure 5).
It is unclear, however, whether MUFAs or PUFAs
play a more prominent role. Foods rich in MUFA are
often also rich in PUFAs, making it difﬁcult to
completely differentiate the effects of the 2 in the
clinical practice. Foods rich in MUFAs and PUFAs
sometimes also contain SFAs, which may explain the
correlation seen also between SFA consumption, CRF,
and diastolic function. This is supported by the
experimental data in mice showing that excess SFA
intake results in cardiac dysfunction, whereas high
UFA intake does not.
Accordingly, advocating for a generalized low-fat
diet may be neutral on CV outcomes (39), if not
indirectly detrimental (40). A low-fat diet may result
in lower consumption of UFAs, precluding the
potential beneﬁcial effects these nutrients exert.
Moreover, advocating for a low-fat diet may increase
the consumption of sugars as substitutes for fat.
The data presented herein showed indeed that
sugar consumption is linked to impaired CRF in
patients with HFpEF, and the experimental data in
mice conﬁrm the toxic effects of a high-sugar diet.
In preclinical studies, a Western-like diet induced
cardiac dysfunction, mainly diastolic, which was
reversed by switching back to a “healthy” diet (12),
and another study in rats showed beneﬁcial effects of
oleic acid–enriched canola oil on cardiac function
(41). These data highlight the ability of diet to
modulate cardiac function in experimental animal
settings, showing that the quality of nutrients rather
than calories affects cardiac function, with a high-
UFA, low-sugar content opposing the detrimental
effects of saturated fat and sugars.
A diet rich in UFAs may also play a protective role
on body composition by increasing the amount of
FFM (42,43) but also improving FFM quality and
FIGURE 4 Diet Modulates Cardiac Function in Mice
Mice fed a Western diet and a high–saturated fatty acids (SFAs) diet presented higher body weight (B), despite similar caloric intake
(A) compared with standard diet and compared with high–unsaturated fatty acids (UFAs) diet. Western diet and high-SFA diet-fed mice
presented diastolic dysfunction (C, D) after 8 weeks. High-UFA-fed mice presented preserved cardiac diastolic function, which was not
different compared with standard diet.
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strength (42). These ﬁndings are particularly relevant
because body composition plays a crucial role in
affecting exercise capacity (44), to the extent that has
been proposed to be the major cause of exercise
intolerance in HFpEF (38).
STUDY LIMITATIONS. Because of the observational
nature of the clinical study, causality between
improved CRF, cardiac function, body composition,
and UFA consumption should not be assumed.
These ﬁndings may also not be replicable in a
normal-weight population with HFpEF.
Additionally, the 24-h dietary recall, although
validated in a number of studies, has its own limita-
tions (26). In this study, a single trained nutritionist
performed all assessments following a standardized
protocol, yet the 24-h recall only allows the collection
of a snapshot of subjects’ dietary patterns and is a
memory-based, indirect measure of dietary intake.
Although bioelectric impedance analysis is not the
gold-standard technique for body composition
assessment, it has been validated in a number of
studies against gold-standard techniques, and we
have recently shown a highly signiﬁcant correlation
with dual-energy x-ray absorptiometric parameters in
HFpEF (9). Finally, the small sample size of the study
should be considered, as it may have negatively
affected the power of other analyses.
In the preclinical study, we included only male
mice. The improved cardiac diastolic function in mice
fed a UFA-enriched and low-sugar diet does not
necessarily translate to improved exercise capacity in
patients with HFpEF. Finally, an assessment of body
composition in mice fed with different diets is lacking.
CONCLUSIONS
In the present study we found an association be-
tween a fat-rich diet, speciﬁcally UFAs (MUFAs and
PUFAs), and CRF, diastolic function, and body
composition in obese patients with HFpEF. The
mouse experiments conﬁrmed the protective effect
of a high-UFA, low-sugar diet. These results call for
targeted dietary interventional randomized trials in
patients with HFpEF aimed at increasing UFA
consumption, with or without caloric and saturated
fat restriction and reduction in sugar consumption.
Moreover, the related molecular mechanisms
involved in these potential beneﬁcial effects require
further investigation.
ADDRESS FOR CORRESPONDENCE: Dr. Salvatore
Carbone, VCU Pauley Heart Center, Virginia Common-
wealth University, West Hospital, 5th Floor, Room 520,
1200 East Broad Street, PO Box 980204, Richmond,
Virginia 23298. E-mail: salvatore.carbone@vcuhealth.org.
FIGURE 5 Potential Role of Diet on Cardiorespiratory Fitness in Heart Failure With Preserved Ejection Fraction
Diet can have detrimental (red arrows) or beneﬁcial (green arrows) effects on cardiorespiratory ﬁtness (CRF). A diet low in monounsaturated
fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) and high sugars may contribute to worsening CRF (red arrows). Conversely, a
diet rich in MUFAs and PUFAs and low in sugars may exert beneﬁcial effects in patients with heart failure with preserved ejection fraction by
increasing CRF through improvements in myocardial relaxation and body composition (green arrows).
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